i saw something about that 6 months ago. the problem is the whole replace the bone marrow part of the stem cell treatment.
the important part of this, is that this may indicate where the virus' reservoir is, and maybe that the human body's antibodies for hiv are enough to prevent a future infection (if you can clear the initial infection)
"Transplants of bone marrow - or, more commonly these days, of blood stem cells - are done to treat cancer, and their risks in healthy people is unknown. It involves destroying the person’s native immune system with powerful drugs and radiation, then replacing it with donor cells to grow a new immune system. Mortality from the procedure or its complications can be 5 percent or more, Saag said."
from comment "So...in addition to risks (which can be lethal!) associated with bone marrow transplantation , one also needs to find the right donor, namely the one who is homozygous for this genetic defect (missing CCR5). And only 5% of population in Europe has this defect."
![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
melanoman
![[identity profile]](https://www.dreamwidth.org/img/silk/identity/openid.png){kind=small}
no subject
Date: 2010-12-15 10:04 am (UTC)the important part of this, is that this may indicate where the virus' reservoir is, and maybe that the human body's antibodies for hiv are enough to prevent a future infection (if you can clear the initial infection)
no subject
Date: 2010-12-16 12:02 am (UTC)"Transplants of bone marrow - or, more commonly these days, of blood stem cells - are done to treat cancer, and their risks in healthy people is unknown. It involves destroying the person’s native immune system with powerful drugs and radiation, then replacing it with donor cells to grow a new immune system. Mortality from the procedure or its complications can be 5 percent or more, Saag said."
from comment
"So...in addition to risks (which can be lethal!) associated with bone marrow transplantation , one also needs to find the right donor, namely the one who is homozygous for this genetic defect (missing CCR5). And only 5% of population in Europe has this defect."